Barclays PLC 23and Me Holding Co. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Barclays PLC holds 1,866 shares of ME stock, worth $5,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,866

Previous 1,866 -0.0%

Holding current value

$5,709

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$0.29 - $0.51 $330 - $580	1,139 Added 156.67%	1,866 $1,000
Q2 2024 Aug 14, 2024	SELL	$0.36 - $0.61 $98,497 - $166,899	-273,605 Reduced 99.73%	727 $0
Q1 2024 May 15, 2024	SELL	$0.4 - $0.91 $79,451 - $180,751	-198,628 Reduced 42.0%	274,332 $146,000
Q4 2023 Feb 15, 2024	BUY	$0.71 - $0.97 $268,735 - $367,145	378,500 Added 400.7%	472,960 $432,000
Q3 2023 Nov 07, 2023	SELL	$0.96 - $2.01 $5,856 - $12,260	-6,100 Reduced 6.07%	94,460 $92,000
Q2 2023 Aug 03, 2023	SELL	$1.59 - $2.29 $51,056 - $73,534	-32,111 Reduced 24.2%	100,560 $176,000
Q1 2023 May 04, 2023	BUY	$2.05 - $2.87 $125,599 - $175,839	61,268 Added 85.81%	132,671 $303,000
Q4 2022 Feb 13, 2023	BUY	$2.06 - $3.47 $124,535 - $209,775	60,454 Added 552.14%	71,403 $154,000
Q3 2022 Nov 03, 2022	BUY	$2.6 - $5.12 $6,034 - $11,883	2,321 Added 26.9%	10,949 $31,000
Q2 2022 Aug 12, 2022	BUY	$2.19 - $3.98 $17,958 - $32,636	8,200 Added 1915.89%	8,628 $21,000
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $1,403 - $3,047	428 New	428 $2,000

Others Institutions Holding ME

# of Institutions

116

Shares Held

82.5M

Call Options Held

404K

Put Options Held

292K

View Full List

About 23andMe Holding Co.

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

More about ME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account